Structures by: Solanko K. A.
Total: 37
Aspirin form II
C9H8O4
Chemical Science (2011) 2, 11 2236
a=12.3578(7)Å b=6.5315(8)Å c=11.4964(7)Å
α=90.00° β=112.436(3)° γ=90.00°
5-chloro-aspirin (form II)
C9H7ClO4
CrystEngComm (2011) 13, 23 6991
a=5.0838(4)Å b=17.9622(15)Å c=10.4409(7)Å
α=90.00° β=98.445(3)° γ=90.00°
5-bromo-aspirin (form II)
C9H7BrO4
CrystEngComm (2011) 13, 23 6991
a=5.0940(2)Å b=17.8642(7)Å c=10.6736(4)Å
α=90.00° β=98.935(2)° γ=90.00°
5-Cl-aspirin anhydride (form I)
C18H12Cl2O7
CrystEngComm (2011) 13, 23 6991
a=10.5412(7)Å b=12.4530(8)Å c=13.5129(10)Å
α=90.00° β=90.00° γ=90.00°
5-Cl-aspirin anhydride (form II)
C18H12Cl2O7
CrystEngComm (2011) 13, 23 6991
a=10.7838(3)Å b=14.2206(4)Å c=12.3774(4)Å
α=90.00° β=107.635(3)° γ=90.00°
5-Br-aspirin anhydride (form II)
C18H12Br2O7
CrystEngComm (2011) 13, 23 6991
a=16.9944(7)Å b=7.9432(4)Å c=14.0330(7)Å
α=90.00° β=105.825(2)° γ=90.00°
5-Me-aspirin anhydride (form I)
C20H18O7
CrystEngComm (2011) 13, 23 6991
a=9.9176(9)Å b=9.9757(10)Å c=11.5419(17)Å
α=95.485(7)° β=109.352(7)° γ=117.882(4)°
5-Me-aspirin anhydride (form II)
C20H18O7
CrystEngComm (2011) 13, 23 6991
a=20.749(2)Å b=8.3818(8)Å c=10.6736(10)Å
α=90.00° β=97.440(5)° γ=90.00°
Felodipine:acetone (1:1)
C18H19Cl2NO4,C3H6O
CrystEngComm (2015) 17, 22 4089
a=9.1774(8)Å b=16.6983(15)Å c=14.3375(11)Å
α=90° β=105.865(4)° γ=90°
Felodipine:acetophenone (1:1)
C18H19Cl2NO4,C8H8O
CrystEngComm (2015) 17, 22 4089
a=7.3940(7)Å b=11.4991(10)Å c=29.003(2)Å
α=90.00° β=90.00° γ=90.00°
Felodipine:dimethylsulfoxide (1:1)
C18H19Cl2NO4,C2H6OS
CrystEngComm (2015) 17, 22 4089
a=8.660(3)Å b=9.816(3)Å c=13.782(4)Å
α=87.37(2)° β=79.17(3)° γ=77.79(3)°
C18H14F4N2O4S,C7H7NO
C18H14F4N2O4S,C7H7NO
CrystEngComm (2016) 18, 25 4818
a=5.7985(11)Å b=11.964(3)Å c=17.496(3)Å
α=101.978(7)° β=97.828(7)° γ=90.114(8)°
C18H14F4N2O4S,C7H7NO2
C18H14F4N2O4S,C7H7NO2
CrystEngComm (2016) 18, 25 4818
a=5.8888(3)Å b=21.5969(11)Å c=19.2814(10)Å
α=90° β=97.821(2)° γ=90°
5-Br-aspirin anhydride (form I)
C18H12Br2O7
CrystEngComm (2011) 13, 23 6991
a=10.5579(5)Å b=12.5176(7)Å c=13.7487(8)Å
α=90.00° β=90.00° γ=90.00°
Felodipine : N,N-dimethylacetamide (1:1)
C18H19Cl2NO4,C4H9NO
CrystEngComm (2013) 15, 30 6054
a=9.1075(4)Å b=15.7970(7)Å c=16.6894(7)Å
α=90.00° β=105.699(1)° γ=90.00°
Felodipine : 1,3-dimethylimidazolidine-2-one (1:1)
C18H19Cl2NO4,C5H10N2O
CrystEngComm (2013) 15, 30 6054
a=28.6544(12)Å b=11.4450(5)Å c=14.5730(6)Å
α=90.00° β=90.715(1)° γ=90.00°
Felodipine : tetramethylurea (1:1)
C18H19Cl2NO4,C5H12N2O
CrystEngComm (2013) 15, 30 6054
a=16.3261(18)Å b=11.4866(11)Å c=14.7468(17)Å
α=90.00° β=111.959(3)° γ=90.00°
Felodipine : 4,4'-bipyridine (1:1)
C18H19Cl2NO4,C10H8N2
CrystEngComm (2014) 16, 29 6603
a=7.7589(10)Å b=9.2634(12)Å c=17.830(2)Å
α=90.403(8)° β=90.275(9)° γ=97.322(9)°
Felodipine : 4,4'-bipyridine (2:1)
2(C18H19Cl2NO4),C10H8N2
CrystEngComm (2014) 16, 29 6603
a=10.4207(9)Å b=10.6061(9)Å c=11.2328(9)Å
α=67.167(4)° β=73.749(4)° γ=81.109(5)°
2,6-bis(2,4-dichlorobenzylidene)cyclohexanone
C20H14Cl4O
CrystEngComm (2011) 13, 6 1768
a=14.4171(8)Å b=8.0418(4)Å c=31.454(2)Å
α=90.00° β=90.00° γ=90.00°
2,6-bis(2,4-dichlorobenzylidene)cyclohexanone
C20H14Cl4O
CrystEngComm (2011) 13, 6 1768
a=14.4059(11)Å b=7.9797(3)Å c=31.467(2)Å
α=90.00° β=90.00° γ=90.00°
2,6-bis(2,4-dichlorobenzylidene)cyclohexanone
C20H14Cl4O
CrystEngComm (2011) 13, 6 1768
a=14.3893(12)Å b=7.9176(4)Å c=31.485(3)Å
α=90.00° β=90.00° γ=90.00°
2,6-bis(2,4-dichlorobenzylidene)cyclohexanone
C20H14Cl4O
CrystEngComm (2011) 13, 6 1768
a=14.3623(6)Å b=7.8230(4)Å c=31.5402(13)Å
α=90.00° β=90.00° γ=90.00°
2,6-bis(2,4-dichlorobenzylidene)cyclohexanone
C20H14Cl4O
CrystEngComm (2011) 13, 6 1768
a=14.3840(5)Å b=7.7638(3)Å c=31.8297(11)Å
α=90.00° β=90.00° γ=90.00°
2,6-bis(2,4-dichlorobenzylidene)cyclohexanone
C20H14Cl4O
CrystEngComm (2011) 13, 6 1768
a=14.3650(5)Å b=7.7434(2)Å c=31.8361(10)Å
α=90.00° β=90.00° γ=90.00°
Aspirin form II
C9H8O4
Chemical Science (2011) 2, 11 2236
a=12.1016(4)Å b=6.4721(2)Å c=11.3344(4)Å
α=90.00° β=111.593(1)° γ=90.00°
2,3-dichlorobenzaldehyde
C7H4Cl2O
Acta Crystallographica Section B (2011) 67, 5 437-445
a=3.7888(3)Å b=13.7784(15)Å c=13.0368(15)Å
α=90.00° β=90.979(5)° γ=90.00°
3,4-dichlorobenzaldehyde
C7H4Cl2O
Acta Crystallographica Section B (2011) 67, 5 437-445
a=3.8094(3)Å b=14.8887(13)Å c=6.2014(5)Å
α=90.00° β=91.849(4)° γ=90.00°
3,5-dichlorobenzaldehyde
C7H4Cl2O
Acta Crystallographica Section B (2011) 67, 5 437-445
a=3.7785(5)Å b=31.353(5)Å c=12.058(2)Å
α=90.00° β=91.546(6)° γ=90.00°
2,5-dichlorobenzaldehyde
C7H4Cl2O
Acta Crystallographica Section B (2011) 67, 5 437-445
a=3.8150(5)Å b=7.8290(11)Å c=17.895(3)Å
α=89.091(5)° β=85.728(5)° γ=81.115(5)°
Felodipine--diazabicyclo[2.2.2]octane--water (1/1/1)
C18H19Cl2NO4,C6H12N2,H2O
Acta Crystallographica Section C (2012) 68, 11 o456-o458
a=11.3003(3)Å b=13.2721(3)Å c=17.2019(4)Å
α=90.00° β=95.398(2)° γ=90.00°
2,6-Bis(2,4-dimethylbenzylidene)cyclohexanone
C24H26O
Acta Crystallographica Section E (2010) 66, 6 o1435
a=6.9784(4)Å b=19.2540(12)Å c=14.2829(10)Å
α=90.00° β=102.179(3)° γ=90.00°
Acetylsalicylsalicylic acid
C16H12O6
Acta Crystallographica Section E (2012) 68, 7 o2108
a=9.6314(5)Å b=7.7548(3)Å c=18.0763(8)Å
α=90.00° β=95.572(2)° γ=90.00°
Felodipine III
C18H19Cl2NO4
Crystal Growth & Design (2012) 12, 8 4022
a=15.1255(18)Å b=7.2302(9)Å c=17.2796(19)Å
α=90.00° β=110.198(7)° γ=90.00°
Felodipine IV
C18H19Cl2NO4
Crystal Growth & Design (2012) 12, 8 4022
a=11.1129(9)Å b=12.5688(11)Å c=13.4969(11)Å
α=90.00° β=107.009(4)° γ=90.00°
Felodipine : 4,4'-bipyridine (1:1)
C18H19Cl2NO4,C10H8N2
CrystEngComm (2014) 16, 29 6603
a=36.197(3)Å b=36.436(3)Å c=8.0228(6)Å
α=90° β=90° γ=90°
2,6-bis(2,4-dichlorobenzylidene)cyclohexanone
C20H14Cl4O
CrystEngComm (2011) 13, 6 1768
a=14.3879(13)Å b=7.8591(8)Å c=31.494(3)Å
α=90.00° β=90.00° γ=90.00°